Pet Allergy Treatment Market By Pet Type (Dog, Cat, Small Animals, Others), By Allergy Type (Environmental Allergies {Pollen, Dust Mites, Mold, Dander, Grass and Weed Allergens}, Food Allergies {Animal Protein, Grains, Dairy Products, Additives}, Contact Allergies, Others), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Biologic Therapies, Dietary Management, Topical Treatments, Natural and Herbal Remedies), By Distribution channel (Veterinary Clinics, Pet Pharmacies, Online Retailers, Pet Specialty Stores,), and By End-user (Pet Owners, Veterinary Clinics, Pet Hospitals, Animal Shelters, Pet Care Services Providers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Pet Allergy Treatment market accounted for USD 2.43 Billion in 2024 and is expected to reach USD 4.86 Billion by 2035, growing at a CAGR of around 6.5% between 2025 and 2035. The pet allergy treatment market consists of products and therapies for managing pet allergic reactions, including skin allergy, food allergy, and environmental allergy. Treatments, along with antihistamines, corticosteroids, immunotherapy, and hypoallergenic diets.

Newer advances in veterinary medicine allow for biologics in the form of monoclonal antibodies, which provide long-term relief from allergies. Growing pet adoption, coupled with increased awareness of pets' health, constitutes major factors boosting the growth of the market. The other factor is that advances in diagnostics are helping veterinarians to identify the allergens involved, thereby customizing the treatment for pets. An increasing proclivity for natural and organic products is also boosting the demand for herbal and holistic treatments for allergies. Probiotics and omega-3 supplements are recommended by veterinarians to help increase the immunity of pets. North America and Europe are key markets on account of high pet ownership and, therefore, the money spent on veterinary care.

Report Scope:

Market Dynamics

Increased adoption of pets worldwide is driving demand for allergy treatments.

The pet allergy treatment market is catching up with the rising global rate of pet adoptions, leading to an increase in allergic reactions triggered by pet dander, saliva, or fur. Urbanization and changes in lifestyle have been the driving factors toward pet ownership in households with children—the very same population that develops most allergic conditions. Such an increase in demand for allergy-targeting solutions has given rise to advances in veterinary healthcare, the spread of awareness around pet allergies, and demand for products such as antihistamines, immunotherapy, and hypoallergenic products for pets.

The thriving human-animal interaction in pet-friendly workspaces, cafés, and other recreational centers contributes to raising demand for allergy management solutions. The CDC states that 10-20% of the world's population is allergic to pets, further substantiating the demand for solutions in the Pet Allergy Treatment Market. Increasing awareness of and availability of diagnostic tests and targeted therapies are additional factors aiding in the growth of the market for the effective management of pet-induced allergies.

Rising pollution and climate change are leading to more allergy cases in pets.

Pollution and climate change are the main factors contributing to the growth of the pet allergy treatment market, as they contribute to an increased number of allergy cases in pets. Pollution, such as air pollutants and pollen levels, can irritate the respiratory system of pets, causing allergic reactions, whereas climate change worsens the situation by changing pollen seasons, increasing the allergen load in the environment, and changing the frequency and severity of allergic episodes in pets. Thereby, more and more pets are developing sensitivities to environmental triggers, which is boosting the demand for effective allergy treatments.

An American Veterinary Medical Association (AVMA) study suggests that environmental factors such as air quality and seasonal changes have led to an increase in allergy-related conditions in pets, with about 10% to 15% of dogs suffering from environmental allergies. This increasing prevalence causes the need for treatment options like antihistamines and immunotherapy in the market.

Long-term use of steroids and antihistamines can lead to health complications in pets.

The prolonged use of steroids and antihistamines as treatments for pet allergies holds great constraint for the pet allergy treatment market due to various health complications they might bring to the pets. Prolonged steroid use and its side effects, including weight gain, diabetes, liver damage, and diminished immune systems, are points of serious concern for pet owners and veterinarians alike.

Long-term use of antihistamines also leads to drowsiness, gastrointestinal problems, and reduced effectiveness over time. The health risks involved urge pet owners to search for alternative, sustainable treatments, which curtail the acceptance of conventional therapies. Hence, the market is faced with the challenge of proving long-term safety and efficacy in the development of newer and safer allergy treatments. Such apprehension acts as a restraint in that it dissuades some pet owners from pursuing long-term solutions for allergy management and impacts the overall growth of the market.

Increasing demand for organic and holistic pet care solutions.

Organic and natural treatments for pets enjoy great demand, thus presenting a large opportunity for the Pet Allergy Treatment Market. Pet owners nowadays are well aware of the possible side effects posed by conventional medicine and are seeking natural and organic alternatives, which they regard as safer and gentler for pets. Such a change in consumer preference is raising irreversible demand for allergy treatment that includes herbal remedies, natural antihistamines, homeopathy, or organic products.

These treatments allow pet owners to relax, knowing that they kept their pets away from harsh chemicals and toward general wellness. It is part of the whole trend toward organic and natural products in health and wellness, which signifies a booming niche within the pet allergy treatment market. Hence, companies targeting holistic solutions can take advantage of this opportunity and enlarge their offerings of products to include organic and natural allergy treatments.

Improved testing methods can lead to the early and precise identification of allergens.

Advancing testing methods are major avenues for the pet allergy treatment market, allowing for early and exact findings regarding pet allergens. Advances in diagnostic technologies, blood tests, skin tests, and genetic tests allow veterinarians to focus better on determining the allergens that bring out the pet's reactions. Earlier and more accurate identification of these allergens may lead to targeted and effective treatment management rather than the traditional trial-and-error approaches associated with allergy management.

More pertinent diagnoses help improve the efficiency of allergy treatment overall, as they increase the success rate while lowering the odds of complications or adverse reaction risks. Therefore, more treatment options are likely to be available in this market as more pet owners adopt treatment solutions based on accurate test results. In addition, better testing methods may be a platform of awareness for pet owners to enhance preventive behaviors for early intervention and increased demand for such treatment options in the market.

Industry Experts Opinion

"In many cases, environmental allergens, such as pollen and mold, are the primary culprits behind pet allergies. Treatment options can include antihistamines, special shampoos, and hypoallergenic diets, but a thorough diagnosis from a veterinarian is essential to determine the best course of action."

• Dr. Karen Becker, DVM

Segment Analysis

Based on the Allergy type, the Pet Allergy Treatment Market has been classified into Environmental Allergies, Food Allergies, Contact Allergies, and Others. Among the many allergy types, environmental allergies dominate the rest and are one of the significant components in the Pet Allergy Treatment Market. Pets, most commonly dogs and cats, are usually attacked by environmental allergens, including pollen, dust mites, mold, and dander, which cause allergic responses of different forms. All these, in addition to pollution and climate change, produce allergens in the air, resulting in increased incidences of these allergies. As a result, therapies, including immunotherapy, allergy injections, and antihistamines that target environmental allergens, have gained popularity. Because environmental allergies are typically all-pervasive and affect a larger number of pets globally, this group continues to hold its dominance and is a significant geographic category. In addition to these factors, the growing number of pet owners and people's knowledge of these allergies are driving the market for environmentally induced treatments.

Based on the Treatment type, the Pet Allergy Treatment Market has been classified into Antihistamines, Corticosteroids, Immunotherapy, Biologic Therapies, Dietary Management, Topical Treatments, and Natural and Herbal Remedies. The immunotherapy segment, which stands as both competitive and essential among all other treatment modalities present in the Pet Allergy Treatment Market. The two forms of allergy shots and sublingual tablets make immunotherapy an effective long-term therapy that treats pet allergies primarily focused on environmental allergies from pollen and dust mites.

The treatment of immunotherapy creates desensitization in the animal immune system toward specific allergens, so animals receive ongoing relief with a reduced need for antihistamines and corticosteroids. The combination of increased environmental allergies in pets with evolving pet owner preferences for sustainable long-term treatments made immunotherapy become the veterinarian and pet owner choice for treatment. Immunotherapy maintains its market demand since pets require extended management to sustain allergic conditions.

Regional Analysis

The pet allergy treatment market shows its largest market share in North America because pet owners demonstrate high ownership figures along with increasing recognition of their allergy conditions. The demand for allergy treatments is rising in the United States and Canada due to an increase in environmental allergies caused by dust mites and pollen as a result of urbanization and climate change. The pet allergy treatment market expands within the region because of better veterinary healthcare facilities, together with the increased availability of effective allergy treatments through immunotherapy and biologic therapies. Alongside organic pet care options, the growing market of pet therapies enhances the expanding pet treatment options throughout North America. Advanced treatments in the global pet allergy treatment market find widespread adoption in North America because of high pet owner buying power as well as the robustness of local healthcare systems.

The rapid expansion of Asia Pacific's pet allergy treatment market results from growing numbers of pet owners and expanding knowledge about animal allergies. Japan, together with China and India, has seen an increase in pet adoption that produces higher numbers of pet allergy cases among urban residents. Demand for effective allergy treatments has increased due to growing environmental allergies that include pollen and dust mites, together with pollution-related allergens. The use of antihistamines and corticosteroids remains widespread for treatment, but market interest grows for natural and holistic therapies. Pets in the region receive better allergy care from the expanding veterinary healthcare infrastructure, together with enhanced diagnostic methods and early identification solutions. The growth of the market in Asia Pacific stems from pet owners seeking advanced treatments because the middle-class population is increasing and disposable income levels are improving.

Competitive Landscape

The pet allergy treatment market features intense competition between major companies Zoetis, Elanco Animal Health, Boehringer Ingelheim, and Ceva Santé Animale because they possess strong veterinary pharmaceuticals and allergy treatment solution offerings. Existing companies dedicate resources to research and development because they seek to create innovative allergy treatments, which include immunological therapies and biologic medications, as well as specific solutions for environmental and food allergy needs.

Three pharmaceutical organizations, including Virbac, Vetoquinol, and Dechra Pharmaceuticals, work toward providing targeted pet allergy treatments through their innovative use of topical treatments and natural remedies.  The market shows the emergence of various smaller pharmaceutical companies, such as ycor Biomedical, Aratana Therapeutics, and Kindred Biosciences, which focus on developing unique allergy treatments and biologics. Various competitors operating in this market segment drive innovation, which leads to many diverse medical solutions available for pet owners.

Pet Allergy Treatment Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In April 2024, Boehringer Ingelheim expanded its dog parasite protection options in India by introducing NexGard SPECTRA, following approval by the Central Drugs Standard Control Organization (CDSCO).
• In May 2023, Elanco Animal Health received a conditional license for a monoclonal antibody treatment against canine parvovirus, enhancing its portfolio in pet healthcare.

Report Coverage:

By Pet Type

• Dog
• Cat
• Small Animals
• Others

By Allergy Type

• Environmental Allergies
  • Pollen
  • Dust Mites
  • Mold
  • Dander
  • Grass and Weed Allergens
• Food Allergies
  • Animal Protein
  • Grains
  • Dairy Products
  • Additives
• Contact Allergies
• Others

By Treatment

• Antihistamines
• Corticosteroids
• Immunotherapy
• Biologic Therapies
• Dietary Management
• Topical Treatments
• Natural and Herbal Remedies

By Distribution channel

• Veterinary Clinics
• Pet Pharmacies
• Online Retailers
• Pet Specialty Stores

By End-user

• Pet Owners
• Veterinary Clinics
• Pet Hospitals
• Animal Shelters
• Pet Care Services Providers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Zoetis
• Elanco Animal Health
• Boehringer Ingelheim
• Ceva Santé Animale
• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Nestlé Purina PetCare
• Royal Canin
• Hill's Pet Nutrition
• Bayer Animal Health
• Merial
• Hycor Biomedical
• Aratana Therapeutics
• Kindred Biosciences

Frequently Asked Questions (FAQs)